HEXAPEPTIDE COMPOSITE WITH STABILIZED DISULFIDE BOND WITH SUBSTANCE-METAL, PHARMACEUTICAL COMPOSITIONS BASED ON SAID, METHODS OF THEIR PREPARING AND USE FOR TREATMENT OF DISEASES BASED ON REGULATION OF METABOLISM, PROLIFERATION, DIFFERENTIATION AND APOPTOSIS MECHANISMS IN NORMAL AND PATHOLOGICAL TISSUES Russian patent published in 2000 - IPC

FIELD: medicine, pharmacology. SUBSTANCE: invention relates to methods of preparing drugs based on active peptide metabolites that can be used in clinical practice. Composite has compound based on oxidized glutathione and substance-metal taken in the ratio = 3 000:1 and 1:1 where substance-metal includes metal taken among the group consisting of platinum and palladium. Oxidized glutathione-base compound can be derivate or salt taken among the group consisting of alkaline metal salts, alkaline-earth metal salts and transient metal salts. Proposed composite stimulates endogenic production of cytokines and hemopoietic factors and can be used for treatment of patients suffering with disease caused by disorders of regulation, metabolism, proliferation, differentiation and cell apoptosis mechanisms. EFFECT: broadened spectrum of agents for stimulation, enhanced and prolonged stimulation. 79 cl, 22 dwg, 42 tbl, 18 ex